Mon03302020

Robins Global News & Noticias



  • Digital Products
    Digital Products
  • IT Career News
    IT Career News
  • Microsoft Exam
    Microsoft Exam
  • Gaming Chair Review
    Gaming Chair Review
  • Youtube Marketing Guide
    Youtube Marketing Guide
  • Slot Game Review
    Slot Game Review

RobinsPost News Network

+ Larger Font | - Smaller Font
Share

Globe NewsWire News Distribution Service

Press Release: Diazyme Laboratories, Inc. Announces Availability of COVID-19 Antibody Tests


SAN DIEGO, CA, March 25, 2020 (GLOBE NEWSWIRE) -- Diazyme announces the availability of two serological tests for the novel coronavirus (SARS-CoV-2), namely the Diazyme DZ-Lite SARS-CoV-2 IgG and SARS-CoV-2 IgM CLIA test kits. The Diazyme IgG and IgM tests are run on the fully automated Diazyme DZ-Lite 3000 Plus chemiluminescence analyzer. The Diazyme serological test notification is now listed on FDA’s EUA website under “FAQs on Diagnostic Testing for SARS-CoV-2”.

“To make the tests available, Diazyme followed the FDA’s Emergency Use Notification process as provided in the FDA’s Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency (March 16, 2020). We thank the FDA for its prompt response to our requests and its guidance in making additional tests available to combat the current novel coronavirus outbreak. Research has shown that after infection with SARS-CoV-2, viral antigens stimulate the body’s immune system to produce antibodies that can be detected with our IgM and IgG tests. The fully automated serological tests that we provide have high specificity, sensitivity and clinical agreement with samples confirmed with the standard nucleic acid testing method (RT-qPCR)" said Dr. Chong Yuan, Managing Director of Diazyme Laboratories.

About Diazyme
Diazyme Laboratories, Inc., a Life Science Affiliate of General Atomics, is located in Poway, California. Diazyme uses its proprietary enzyme and immunoassay technologies to develop diagnostic reagents run on automated chemistry analyzers and chemiluminescence instruments in user-friendly formats. Diazyme is a cGMP and ISO 13485 certified medical device manufacturer. Information regarding Diazyme's technology and products can be found on its website at www.diazyme.com

Required Notice:

  • For Rx use only.
  • This test has not been reviewed by the FDA. For use in clinical laboratories by health care professionals following FDA guidance “Policy for Diagnostic Tests for Coronavirus Disease-2019 (COVID-19) during the Public Health Emergency”.
  • Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic assay should be considered to rule out infection in these individuals.
  • Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.
  • Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.
  • Not for the screening of donated blood

For Further Information Contact:
Regulatory/Operational
Abhijit Datta, Ph.D. 
@diazyme.com" rel="nofollow" target="_blank" title>This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.

Sales 
Emile Dergham
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.



Posted: 2020-03-26 00:45:00

Get Full News Story On GlobeNewsWire Press Release Service


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.








Related News Stories From The Web And More

Related Bing News Search Results

Press Release: Diazyme Laboratories, Inc. Announces Availability of COVID-19 Antibody Tests | Globe NewsWire News Distribution Service | RobinsPost News Network - Newscast

Coronavirus ‘menacing the whole of humanity' as cases accelerate in New York

Thu, 26 Mar 2020 04:01:00 GMT

#COVID19 is menacing the whole of humanity – and so the whole of humanity must fight back. Today we are launching a $2 billion global humanitarian response plan to fund the fight against #coronavirus ...

Indian doctors want UK PM to scrap ‘unfair’ surcharge as health service battles COVID19

Thu, 26 Mar 2020 03:28:00 GMT

London, Mar 26 (PTI) Indian doctors working within the UK's state-funded National Health Service (NHS) have written to British Prime Minister Boris Johnson to scrap an “unfair and discriminatory” ...

Innovent Biologics Enters into a Collaboration with Alector to Develop and Commercialize Anti-SIRP-alpha Antibody in China

Wed, 25 Mar 2020 20:57:00 GMT

AL008 is Alector's novel antibody targeting the CD47-SIRP-alpha ... help advance China's biopharmaceutical industry, improve drug availability to ordinary people and enhance the quality of the ...

Can blood from coronavirus survivors treat the newly ill?

Tue, 24 Mar 2020 18:02:00 GMT

The FDA is “working expeditiously to facilitate the development and availability of convalescent ... test if giving infusions of survivors’ antibody-rich plasma to newly ill COVID-19 patients ...

Health Secretary Matt Hancock announces 3.5million antibody tests have been purchased - as new coronavirus testing facility opens TODAY

Tue, 24 Mar 2020 02:20:00 GMT

Health Secretary Matt Hancock today announced the government has purchased 3.5million antibody tests ... have spoken of the availability in the near future of tests for the antibodies that will ...

Related News Story Videos From Youtube






Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
© 2008-2020 RobinsPost (The Bird's Eye View Company) All rights are reserved.
RobinsPost provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by news sources.
News stories, videos and live streams are from trusted sources:
Bing News, Google News, Faroo News, NewsApi.org and YouTube Search Results.
ROBINSPOST Is Proudly Made In America.
Where Quality, Safety and Service Comes First.